1)淮北师范大学体育学院,淮北 235000;2)山东体育学院运动休闲学院,济南 250102
国家社会科学基金(25BTY032)资助项目。
1)School of Physical Education, Huaibei Normal University, Huaibei 235000, China;2)School of Sports and Leisure, Shandong Sport University, Jinan 250102, China
This work was supported by a grant from The National Social Science Foundation of China (25BTY032).
本文旨在系统评价极低热量生酮饮食(VLCKD)、地中海饮食(MD)与间歇性禁食(IF)对肥胖人群肠道菌群的影响。截至2025年9月,检索PubMed、EBSCOhost、Cochrane和Web of Science四个电子数据库。采用R软件进行荟萃(meta)分析,评估肠道菌群多样性和特征菌群丰度变化。依据身体质量指数(BMI)、年龄和干预周期等变量开展亚组分析。共纳入42项研究。通过随机效应荟萃分析,结果显示,VLCKD显著提升Shannon指数、观测到的操作分类单元(Observed OTU)和系统发育多样性(phylogenetic diversity,PD)指数,并增加阿克曼菌属丰度与厚壁菌门/拟杆菌门比值(F/B比值),但伴随双歧杆菌属丰度的显著下降,提示其双向调节效应。MD干预显著增加Shannon指数、阿克曼菌属和双歧杆菌属丰度,同时降低厚壁菌门和F/B比值,整体呈现稳定、持续的正向作用。IF干预会导致PD指数和厚壁菌门下降、阿克曼菌属上升,但长期干预时Shannon指数出现回落,显示其稳定性有限。亚组分析提示,年龄与BMI是影响菌群多样性和特征菌群变化的重要调节因素。VLCKD、MD与IF均可在肥胖人群中改善肠道菌群结构,但效应特征存在显著差异。VLCKD调节效应强烈但伴随潜在风险,MD稳定性与安全性较高,而IF效果更具选择性且容易导致肥胖人群暴饮暴食,故需要进一步研究其长期可行性和安全性。未来研究应聚焦于膳食模式的最优周期与联合应用,并结合人群特异的饮食习惯和菌群特征,发展个体化的微生态干预策略。
Obesity has become a major global public health concern, affecting more than one billion individuals worldwide. As a low-grade chronic inflammatory condition, obesity is closely associated with cardiometabolic disorders and gut microbial dysbiosis. Diet-based interventions are recognized as one of the safest and most effective strategies for long-term weight management. Increasing evidence indicates that specific dietary patterns can modulate gut microbiota (GM) composition and metabolic function. However, comparative evidence regarding the effects of different dietary strategies remains limited and inconsistent. This systematic review and meta-analysis comprehensively evaluated the effects of the very-low-calorie ketogenic diet (VLCKD), Mediterranean diet (MD), and intermittent fasting (IF) on gut microbiota in obese populations. Systematic searches of PubMed, EBSCOhost, Cochrane, and Web of Science were conducted up to September 2025. Meta-analyses using R software assessed changes in microbial diversity and characteristic taxa abundance, with subgroup analyses by body mass index (BMI), age, and intervention duration. A total of 42 studies were included. Random-effects meta-analysis revealed that VLCKD significantly increased the Shannon index, observed OTUs, and Faith’s phylogenetic diversity (PD), promoted Akkermansia abundance and the Firmicutes/Bacteroidetes (F/B) ratio, but reduced Bifidobacterium abundance, indicating a bidirectional regulatory effect on gut microbial structure. MD significantly increased the Shannon index as well as the abundance of Akkermansia, Bifidobacterium, and Bacteroidetes, while decreasing Firmicutes abundance and the F/B ratio, suggesting a balanced and sustained improvement in gut microbial composition. In contrast, IF significantly decreased the PD index while increasing Akkermansia and reducing Firmicutes, reflecting partial structural optimization but limited enhancement of phylogenetic diversity; long-term interventions were associated with a decline in Shannon diversity, indicating limited stability. Subgroup analyses revealed distinct moderator effects. Under VLCKD, improvements in microbial diversity were more pronounced among individuals with BMI≤30 kg/m2 and those aged >30 years, and meta-regression confirmed that the magnitude of diversity gains increased with age. Regarding BMI, increases in Akkermansia abundance were most evident in individuals with BMI 30-35 kg/m2, whereas Bifidobacterium abundance significantly decreased in the same range, suggesting a threshold-dependent microbial response to adiposity. With respect to age, both Akkermansia (increase) and Bifidobacterium (decrease) exhibited significant changes in individuals aged >40 years. In terms of intervention duration, Akkermansia increased significantly within 6 weeks, while Bifidobacterium decreased within 12 weeks. For MD, increases in Shannon diversity were consistently observed across all BMI, age, and duration subgroups; notably, Akkermansia abundance increased significantly among participants with BMI>30 kg/m2, aged 30-50 years, and during interventions ≤6 months, while Bifidobacterium abundance rose markedly in participants with BMI≤30 kg/m2, aged 40-50 years, and during interventions of 6-12 months. Under IF, Shannon diversity increased significantly in individuals with BMI≤30 kg/m2 and aged >40 years but declined when the intervention exceeded 4 weeks, suggesting reduced long-term stability. In conclusion, VLCKD, MD, and IF all modulate gut microbiota in obesity but differ in magnitude, direction, and durability. VLCKD exerts strong yet dual effects—enhancing diversity while reducing beneficial taxa; MD shows stable, sustained modulation; whereas IF offers selective improvements but lowers phylogenetic diversity with limited persistence. Future studies should conduct large, multicenter randomized controlled trials to determine optimal intervention duration, confirm the moderating roles of age and BMI, and develop personalized microbiota-based dietary strategies for obesity management and gut health improvement.
王舜,包子涵,赵梦琪,李梓阳,王训令,刘凤虎.膳食模式干预对肥胖人群肠道菌群的调控作用:系统评价与荟萃分析[J].生物化学与生物物理进展,2025,52(12):3125-3148 WANG Shun, BAO Zi-Han, ZHAO Meng-Qi, LI Zi-Yang, WANG Xun-Ling, LIU Feng-Hu. Impact of Dietary Pattern Interventions on Gut Microbiota in Obesity: a Systematic Review and Meta-analysis[J]. Progress in Biochemistry and Biophysics,2025,52(12):3125-3148
复制

扫码关注 生物化学与生物物理进展 ® 2026 网站版权 ICP:京ICP备05023138号-1 京公网安备 11010502031771号
